Overview

Silybin - Vitamin E- Phospholipids Complex Reduces Liver Fibrosis in Patients With Chronic Hepatitis C Treated With Peg-IFN-a and RBV

Status:
Completed

Trial end date:
2012-12-01

Target enrollment:

Participant gender:

Summary

Chronic hepatitis C is both a virologic and a fibrotic disease, with mortality resulting mainly from the complications of cirrhosis and HCC. The investigators' aim will be to evaluate the impact on of supplementation with a new pharmaceutical complex of silybin-vitamin E-phospholipids in patients with chronic hepatitis C treated with Pegylated-Interferon-α2b plus Ribavirin.

Phase:

Phase 3

Details

Lead Sponsor:

University of Catania

Treatments:

alpha-Tocopherol
Silybin
Tocopherols
Tocotrienols
Vitamin E
Vitamins